Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Neoplasms 1Depressive Disorder, Major 1Depression 1

Interventions

Surveys and Questionnaires 9Psychiatric Rehabilitation 7Therapeutics 2Interviews as Topic 2Chemotherapy, Adjuvant 2pegfilgrastim 1enzalutamide 1darolutamide 1apalutamide 1Vortioxetine 1Venlafaxine Hydrochloride 1Transurethral Resection of Prostate 1Thyroidectomy 1Tamoxifen 1Standard of Care 1Single Person 1Sertraline 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiosurgery 1Physical Examination 1Palliative Care 1Observation 1Models, Nursing 1Metformin 1Mental Status and Dementia Tests 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Depression × Vortioxetine × Clear all
NCT04253678 2020-02-05

Vortioxetine for Cancer Patients With Depression: An Observational Study

University of Malaya

Unknown
140 enrolled

Depression, Depressive Disorder, Major, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡